DiaMedica Therapeutics, Inc.

  • Home
  • Our Focus
    • Overview
    • Literature & Publications
  • Pipeline
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • Clinical Trials
    • Overview
    • Preeclampsia
    • Acute Ischemic Stroke
  • ReMEDy2 Trial
    • Overview
    • About ReMEDy2
    • Stroke Disease
    • For Physicians
    • Trial Locations
  • About DiaMedica
    • Overview
    • Leadership
    • Careers
    • Contact
  • Investors Relations
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Data
    • Analyst Coverage
    • Financial Reports & SEC Filings
    • Governance
    • Resources

Press Releases

Investors Relations

Investors Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Data
    • Nasdaq Quote
    • Charts
    • Historical Data
  • Analyst Coverage
  • Financial Reports & SEC Filings
    • SEC Filings
    • Annual Reports
    • Tax Information (PFIC)
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • Investor Contact
    • FAQ
    • Share Consolidation Instructions
    • Email Alerts
May 25, 2022 4:15pm EDT

DiaMedica Therapeutics to Attend the 19th Annual Craig-Hallum Institutional Investor Conference Wednesday, June 1, 2022

May 04, 2022 4:32pm EDT

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results

Apr 28, 2022 8:15am EDT

DiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022

Mar 14, 2022 4:45pm EDT

DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results

Mar 08, 2022 8:13am EST

DiaMedica Therapeutics to Report Fourth Quarter 2021 Financial Results and Provide a Business Update March 15, 2022

Feb 02, 2022 8:43am EST

DiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial Officer

Jan 25, 2022 8:43am EST

DiaMedica Therapeutics to Present Research at International Stroke Conference

Jan 05, 2022 8:40am EST

DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer

Dec 13, 2021 8:23am EST

DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event

Nov 17, 2021 8:23am EST

DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

  • Previous
  • 1…
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • …16
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
© 2025 DiaMedica Therapeutics, Inc. All Rights Reserved.
Twitter LinkedIn
Privacy Policy Disclaimer Sitemap